Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in calabar, Nigeria

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Meremikwu, Martin M ^a   Odey, Friday ^a   Oringanje, Chioma ^a   Oyo Ita, Angela ^a   Effa, Emmanuel ^a   Esu, Ekpereonne B ^a   Eyam, Eyam ^a   Oduwole, Olabisi ^a   Asiegbu, Vivian ^a   Alaribe, Ambrose ^a   Ezedinachi, Emmanuel N ^a  

^a UNIVERSITY OF CALABAR   (Nigeria)

Author keywords

Artemisinin; Combination therapy; Falciparum malaria; Naphthoquine

Indexed keywords

ARCO; ARTEMISININ; ARTEMISININ PLUS NAPHTHOQUINE; NAPHTHOQUINONE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTEMISININ-NAPHTHOQUINE COMBINATION; DRUG COMBINATION;

ADOLESCENT; APPETITE DISORDER; ARTHRALGIA; ARTICLE; BITTER TASTE; BLISTER; BODY PAIN; CHILD; CLINICAL TRIAL; COLD SENSATION; COUGHING; DIARRHEA; DIZZINESS; DROWSINESS; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FEMALE; HEARING IMPAIRMENT; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NAUSEA; NIGERIA; PAIN; PRESCHOOL CHILD; PRURITUS; RISK REDUCTION; SCHOOL CHILD; SIDE EFFECT; SINGLE DRUG DOSE; SORE THROAT; STOMACH DISCOMFORT; SWELLING; TABLET FORMULATION; THROAT IRRITATION; TREATMENT OUTCOME; UNPLEASANT SENSATION; VOMITING; WAIST PAIN; WEAKNESS; ADULT; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; MALARIA, FALCIPARUM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; NAPHTHOQUINONES; NIGERIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870685188     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-413     Document Type: Article

References (23)

1. Federal Ministry of Health, National malaria control programme Abuja, Nigeria: Federal Ministry of Health 2005 Annual report. 2005
2. New trends in chloroquine efficacy in the treatment of malaria: chloroquine resistant plasmodium falciparum in anambra and Benue states of Nigeria. Ezedinachi ENU, Ejezie GC, Usanga EA, Gemade EII, Ikpatt NW, Alaribe AAA, Cent Afr J Med 1991 37 180 186 1790563
3. Efficacy of antimalarials in a population study; efficacy and tolerability of a low-dose mefloquine-sulfadoxine-pyrimethamine combination. Ezedinachi ENU, Ekanem OJ, AmJTrop Med Hyg 1999 61 114 119
4. Federal Ministry of Health, Federal Republic of Nigeria National Antimalarial Treatment policy Abuja-Nigeria: National Malaria And Vector Control Division 2005
5. Modelling a predictable disaster: the rise and spread of drug-resistant malaria. Hastings IM, D'Alessandro U, Parasitol Today 2000 16 340 347 10.1016/S0169-4758(00)01707-5 10900482
6. World Health Organization, Antimalarial drug combination therapy Geneva: WHO Report of a WHO technical consultation. 2001 WHO/CDS/RBM/2001.35
7. The search for effective and sustainable treatments for plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations. Watkins WM, Sibley CP, Hastings IM, AmJTrop Med Hyg 2005 72 163 173
8. Averting a malaria disaster. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK, Danis M, Greenwood BM, Anderson RM, Olliaro P, Lancet 1999 353 1965 1967 10.1016/S0140-6736(98)07367-X 10371589
9. Therapeutic effect of dihydroartemisinin combined with naphthoquine phosphate in patients with falciparum malaria. Wang SQ, Meng F, Shen H, Wen Y, Zhuo KR, Zhu QX, Pang XJ, Lin SG, Zeng LH, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2002 20 180 182 12568004
10. Efficacy of naphthoquine, artemisinin and a combination of the two drugs in the treatment of falciparum malaria. Wang JY, Shan CQ, Fu DD, Sun ZW, Ding DB, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2003 21 131 133 14628338
11. Efficacy of oral single dose therapy with artemisinin-naphthoquine phosphate in uncomplicated falciparum malaria. Tun T, Tint HS, Lin K, Kyaw TT, Myint MK, Khaing W, Tun ZW, Acta Trop 2009 111 275 278 10.1016/j.actatropica. 2009.05.007 19464245
12. Naphthoquine phosphate and its combination with artemisinin. Wang JY, Cao W, Shan CQ, Zhang M, Li GF, Ding DB, Shi YL, Wu BA, AMMS China, Acta Trop 2004 89 375 381 10.1016/j.actatropica.2003.11.008 14744564
13. World Health Organization, Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria Geneva: World Health Organization 2003 1 62 WHO/HTM/RBM/2003.50
14. Severe falciparum malaria. World Health Organization, Trans R Soc Trop Med Hyg 2000 94 Suppl. 1 1 90 10748883
15. The microscopic diagnosis of malaria. Shute GT, Principle and practice of malariology Edinburgh: Churchill Livingstone, Wernsdorfer W, McGregor IA, 1988 781 814
16. Artemisinin-naphthoquine combination (ARCO™) therapy for uncomplicated falciparum malaria in adults of Papua New guinea: a preliminary report on safety and efficacy. Hombhanje FW, Linge D, Saweri A, Kuanch C, Jones R, Toraso S, Geita J, Masta A, Kevau I, Hiawalyera G, Sapuri M, Malar J 2009 8 196 10.1186/1475-2875-8-196 19671190
17. Comparative, randomized clinical trial of artemisinin/napthoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in cote d'Ivoire. Toure OA, Penali LK, Yapi J, Ako BA, Toure W, Djerea K, Gomez GO, Makaila OA, Malar J 2009 8 148 10.1186/1475-2875-8-148 19575797
18. Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial. Meremikwu M, Alaribe AAA, Ejemot R, Oyo-Ita A, Ekenjoku J, Nwachukwu C, Ordu D, Ezedinachi ENU, Malar J 2006 5 43 10.1186/1475-2875-5-43 16704735
19. Comparative clinical trial of two-fixed combinations dihydroartemisinin- naphthoquine-trimethoprim (DNP) and artemether-lumefantrine (coartem/riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand. Krudsood S, Chaleemurt K, Pengruksa C, Srivilairit S, Silachamroon U, Treeprasertsuuk S, Brittenham GM, Looareesuwan S, S E Asian J Trop Med Public Health 2003 34 316 321
20. A randomized trial of artemether-lumefantrine versus mefloquine- artesunate for the treatment of uncomplicated multi-drug resistant plasmodium falciparum on the western border of Thailand. Hutagalung R, Piphun L, Ashley EA, McGready R, Brockman A, Thwait KL, Singhasivanon P, Jelinek T, White NJ, Nosten FH, Malar J 2005 4 46 10.1186/1475-2875-4-46 16179089
21. Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated plasmodium falciparum malaria in Senegal. Faye B, Ndiaye JL, Ndiaye D, Dieng Y, Faye O, Gaye O, Malar J 2007 6 80 10.1186/1475-2875-6-80 17570848
22. Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments. Gbotosho GO, Sowunmi A, Happi CT, Okuboyejo TM, AmJTrop Med Hyg 2011 84 936 943 10.4269/ajtmh.2011.10-0722
23. The threat of artemisinin-resistant malaria. Dondorp AM, Fairhurst RM, Slutsker L, MacArthur JR, Breman JG, Guerin PJ, Wellems TE, Ringwald P, Newman RD, Plowe CV, N Engl J Med 2011 365 1073 1075 10.1056/NEJMp1108322 21992120